Waxsen Lifescience Private Limited
About Waxsen Lifescience Private Limited
Data last updated:
Waxsen Lifescience Private Limited is a private limited company based in Mumbai, Maharashtra, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 November 2009.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24297MH2009PTC197046. Its GSTIN is 27AAACW9027C2ZE (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.95 Lakh. It is led by directors including Ritesh Kumar Adatiya (Irp/Rp/Liquidator) and Suresh Chand Mandhana.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 411 Atlanta Estate Near Virwani Indl. Estate Western Express Highway Goregaon (E), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2019, the company reported a revenue of ₹8.64 Cr, a decline of 50% compared to the previous year. For the same year it recorded a net profit of ₹12.55 Lakh (net margin 1.5%) and EBITDA of ₹2.14 Cr (EBITDA margin 24.7%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years.
The company has about 26 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹14.15 Cr and satisfied charges of ₹48 Lakh on record. Court records list 14 cases involving the company, including 2 filed by the company and 12 filed against it.
Company details
Contact details
Waxsen Lifescience Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address411 Atlanta Estate Near Virwani Indl. Estate Western Express Highway Goregaon (E), Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Waxsen Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Waxsen Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Waxsen Lifescience Private Limited, buy the company report.
Financials of Waxsen Lifescience Private Limited
FY 2019 filings availableWaxsen Lifescience Private Limited reported revenue of ₹8.64 Cr (down 50% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 25% over three years, including a 50% fall in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹8.64 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.7% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Waxsen Lifescience Private Limited, buy the company report.
Board of directors of Waxsen Lifescience Private Limited
Waxsen Lifescience has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritesh Kumar Adatiya | Irp/Rp/Liquidator | 10 Apr 2023 | 3 Years 6 Months | As last reported |
| Subhash Agarwal | Additional Director | 10 Feb 2022 | 4 Years 8 Months | As last reported |
| Suresh Chand Mandhana | Director | 17 Feb 2014 | 12 Years 8 Months | As last reported |
| Shilpi Mandhana Also directs: A-Mark Pharma Private Limited | Director | 09 Aug 2010 | 16 Years 2 Months | As last reported |
Peer comparison
Waxsen Lifescience Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atilus Pharma Private Limited | ₹8.68 Cr (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Pehal Life Sciences Private Limited | ₹8.66 Cr (FY 2024) | -33.0% | Mumbai, Maharashtra, India | |||
| Waxsen Lifescience Private Limitedthis company | ₹8.64 Cr (FY 2019) | ₹12.55 Lakh | 1.5% | -50.0% | 26 | Mumbai, Maharashtra, India |
| Srikar Chem & Pharma India Private Limited | ₹8.6 Cr (FY 2024) | -11.0% | Hyderabad, Telangana, India | |||
| Zahidi Pharmaceuticals Private Limited | ₹8.6 Cr (FY 2025) | 2.0% | Umbergaon, Gujarat, India |
To see the full peer comparison of Waxsen Lifescience Private Limited, buy the company report.
Auditor
Waxsen Lifescience Private Limited is audited by BAKLIWAL & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BAKLIWAL & CO | FY 2019 | 130381W |
Shareholding
The shareholding of Waxsen Lifescience Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Waxsen Lifescience Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Oct 2014 | 10557364 | Others | ₹14.15 Cr | Open | |
| 24 Jul 2012 | 10374431 | Bank of Baroda | ₹48 Lakh | Satisfied |
To see the full charge records of Waxsen Lifescience Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Waxsen Lifescience Private Limited has 14 court cases on record: 2 filed by Waxsen Lifescience, 12 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 9 | 0 |
| NCLT | 3 | 2 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (Chamber Summons) | Filed against the company by Haresh Overseas Pvt. Ltd. | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Execution petition | Filed against the company by Haresh Overseas Pvt. Ltd. | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by Haresh Overseas Pvt Ltd | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Haresh Overseas Pvt Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Haresh Overseas Private Limited | Disposed |
To see the full case history of Waxsen Lifescience Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Waxsen Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Waxsen Lifescience Private Limited has a workforce of 26 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Waxsen Lifescience has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACW9027C2ZE | Maharashtra | Active | 03 May 2023 |
| 24AAACW9027C1ZL | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Waxsen Lifescience Private Limited, buy the company report.
Recent activity
Waxsen Lifescience Private Limited has 7 board changes on record since 2010: 4 appointments and 3 cessations. The latest: Ritesh Kumar Adatiya was appointed as Irp/Rp/Liquidator on 10 Apr 2023.
3 earlier events are in the company report.
Frequently asked questions
Waxsen Lifescience is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Waxsen Lifescience is a company under insolvency, formerly operating as a private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 November 2009 and is registered under CIN U24297MH2009PTC197046. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Waxsen Lifescience has 4 current directors:
- Subhash Agarwal - Additional Director
- Suresh Chand Mandhana - Director
- Shilpi Mandhana - Director
- Ritesh Kumar Adatiya - Irp/Rp/Liquidator
The latest financial statements of Waxsen Lifescience on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Waxsen Lifescience is U24297MH2009PTC197046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Waxsen Lifescience has open charges of ₹14.15 Cr and satisfied charges of ₹48 Lakh as per latest MCA filings.
Waxsen Lifescience has 14 court cases on record: 2 filed by the company and 12 filed against it. Most are in the district courts.
Waxsen Lifescience was incorporated on 12 November 2009. It is registered with the Registrar of Companies, Mumbai.
The peers of Waxsen Lifescience by revenue are Atilus Pharma Private Limited, Pehal Life Sciences Private Limited, Srikar Chem & Pharma India Private Limited, Zahidi Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ritesh Kumar Adatiya was appointed as Irp/Rp/Liquidator on 10 Apr 2023. Subhash Agarwal was appointed as Additional Director on 10 Feb 2022. Jayram Subbanna Shetty ceased to be Director on 24 Feb 2014. Waxsen Lifescience has 7 board changes on record in total.
The registered office of Waxsen Lifescience is at 411 Atlanta Estate Near Virwani Indl. Estate Western Express Highway Goregaon E, Mumbai, Maharashtra, India – 400063.